Navigation Links
Rice's Barron wins World Technology Award for Materials
Date:10/27/2011

HOUSTON -- Andrew Barron, Rice University's Charles W. Duncan, Jr. -- Welch Chair of Chemistry and professor of materials science, is the winner of the prestigious 2011 World Technology Award for Materials. The award was presented at the World Technology Summit and Awards gala at the United Nations Oct. 26.

Barron's research focuses on the application of nanotechnology to fundamental problems in energy and health research. His research group has projects involving down-hole sensors, carbon dioxide mitigation and cancer treatment. Barron joined Rice in 1995.

The World Technology Awards are presented annually by the World Technology Network in association with TIME, Fortune, CNN, Science magazine and Technology Review. With members from more than 60 countries, the World Technology Network is an exclusive community of innovative individuals, companies and organizations in science, technology and related fields.

Barron is the author of more than 380 scientific publications, five books and 20 patents. His research group is the core of a number of Rice startup companies, including businesses that range from oil and gas production (Oxane Materials Inc.) to solar power systems (Natcore Technology Inc.) and water purification (Molecular Filtration Inc).

Barron is a fellow of the Royal Society of Chemistry and the recipient of several national and international awards, including the Hmboldt Senior Scientist Research Award, the Corday Morgan Medal and Prize, the Meldola Medal and Prize and the first Welch Foundation Norman Hackerman Award. In 2009 Barron was appointed as the first Prince of Wales Visiting Innovator, and he won the Houston Technology Center's 2011 Lifetime Achievement Award in Nanotechnology.

The World Technology Awards are presented in 20 categories for "innovative work of the greatest likely long-term significance" to humanity. Award winners are nominated and selected by their peers and by a panel of advisors that includes: Ray Kurzweil, inventor and futurist; Jason Pontin, editor and publisher of Technology Review magazine; Lev Grossman, senior writer at TIME magazine and co-author of the "Techland" blog at TIME.com; Oliver Morton, energy and environment editor at The Economist; and Albert Teich, former director of science and policy programs at the American Association for the Advancement of Science.


'/>"/>
Contact: Jade Boyd
jadeboyd@rice.edu
713-348-6778
Rice University
Source:Eurekalert

Related biology technology :

1. Beckman Coulter Prices $500 Million Senior Notes Offering
2. Cephalon Prices 5 Million Shares of Common Stock and $435 Million in 2.50% Convertible Senior Subordinated Notes in Public Offerings
3. Idenix Pharmaceuticals Prices Underwritten Offering of Common Stock
4. Pre-Owned Prices on Premium Pharmaceutical Equipment
5. PriceSpective Continues Global Expansion With New San Diego Office
6. PriceSpective Appoints Colasante as a Vice President and Murdoch as a Director
7. Novavax Prices Public Offering of Common Stock
8. NeoStem Prices Public Offering of 5,000,000 Shares of Common Stock
9. BioMed Realty, L.P. Prices Private Offering of $250 Million of 6.125% Senior Unsecured Notes Due 2020
10. OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering
11. YM BIOSCIENCES PRICES $40 MILLION PUBLIC OFFERING
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2017)... ... August 17, 2017 , ... ... market news outlet had provided a research update on Aytu Bioscience and cited ... product. , According to Soulstring, prescription rates for Natesto® have more than doubled ...
(Date:8/16/2017)... ... 16, 2017 , ... Tunnell Consulting announced today that four of ... Annual Meeting and Expo , to be held October 29 through November 1 in ... innovation to advance patient therapies.” , The ISPE Annual Meeting and Expo will feature ...
(Date:8/16/2017)... ... August 16, 2017 , ... ... a different cell type. Many treatments for specific cancers, such as breast, prostate, ... targeted treatment is androgen deprivation therapy for advanced prostate cancer. , This ...
(Date:8/16/2017)... (PRWEB) , ... August 16, 2017 , ... ... beneficial microbe delivery system, announced it has secured $2M in funding from an ... City Angels, Carmen Innovations, and SVG Thrive Fund. With this investment, 3Bar is ...
Breaking Biology Technology:
(Date:4/3/2017)... , April 3, 2017  Data ... precision engineering platform, detected a statistically significant ... product prior to treatment and objective response ... the potential to predict whether cancer patients ... to treatment, as well as to improve ...
(Date:3/30/2017)... YORK , March 30, 2017 Trends, ... type (physiological and behavioral), by technology (fingerprint, AFIS, iris ... voice recognition, and others), by end use industry (government ... and immigration, financial and banking, and others), and by ... Europe , Asia Pacific , ...
(Date:3/27/2017)... 27, 2017  Catholic Health Services (CHS) has ... Society (HIMSS) Analytics for achieving Stage 6 on ... . In addition, CHS previously earned a place ... an electronic medical record (EMR). "HIMSS ... of EMR usage in an outpatient setting.  This ...
Breaking Biology News(10 mins):